Evidence map›Paper›PMID 26043274›Full record

ReviewToxins2015

A novel Peptide-binding motifs inference approach to understand deoxynivalenol molecular toxicity.

Yousef I Hassan, Christena Watts, Xiu-Zhen Li, Ting Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. 3-keto-DON, but Not 3-International journal of molecular sciences · 2022
    Article
  3. Article
  4. A Novel Deoxynivalenol-Activated WheatJournal of fungi (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yousef I HassanGuelph Food Research Centre, Agriculture and Agri-Food Canada (AAFC), Guelph, ON N1G 5C9, Canada. yousef.hassan@agr.gc.ca.
Christena WattsGuelph Food Research Centre, Agriculture and Agri-Food Canada (AAFC), Guelph, ON N1G 5C9, Canada. christina.watts@agr.gc.ca.
Xiu-Zhen LiGuelph Food Research Centre, Agriculture and Agri-Food Canada (AAFC), Guelph, ON N1G 5C9, Canada. xiu-zhen.li@agr.gc.ca.
Ting ZhouGuelph Food Research Centre, Agriculture and Agri-Food Canada (AAFC), Guelph, ON N1G 5C9, Canada. Ting.Zhou@agr.gc.ca.
Agriculture and Agri-Food Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deoxynivalenol (DON) is a type B trichothecene mycotoxin that is commonly detected in cereals and grains world-wide. The low-tolerated levels of this mycotoxin, especially in mono-gastric animals, reflect its bio-potency. The toxicity of DON is conventionally attributed to its ability to inhibit ribosomal protein biosynthesis, but recent advances in molecular tools have elucidated novel mechanisms that further explain DON's toxicological profile, complementing the diverse symptoms associated with its exposure. This article summarizes the recent findings related to novel mechanisms of DON toxicity as well as how structural modifications to DON alter its potency. In addition, it explores feasible ways of expanding our understating of DON-cellular targets and their roles in DON toxicity, clearance, and detoxification through the utilization of computational biology approaches.

Indexed as

Amino Acid MotifsAnimalsGenomeHumansPeptidesProtein BindingTrichothecenesdeoxynivalenolPeptidesTrichothecenescomputational biologydeoxynivalenolenzymemodificationtoxicity

Identifiers

PMID26043274
PMCPMC4488686
OpenAlexW1537401029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.